Facility risk assessment designed by iPharmatec Solutions for our existing Oral Solid Dosage OEL 4 facility isvery comprehensive and it enabled us to find associated risk and technical risk mitigation recommendations.
Global Technical Head – Quality & OperationsInternational Pharmaceutical Client– GCC
Risk based Validation program established by iPharmatec Solutions for our sterile and non-Sterile facility is very concise and easy to explain to auditors. The approach has reduced the validation efforts based on assessment.
Vice-President
Quality International Pharmaceutical Client - GCC
iPharmatec Solutions provided great insight during our WHO audit for sterile injectable facility. QMS established by them is commendable.
Plant HeadInternational Pharmaceutical Client - Russia
iPharmatec Solutions performed GMP Gap Analysis of our existing multi-production OSD facility and provided step by step exceptional guidance on compliance implementation.
General Manager- QualityInternational Pharmaceutical Client - Bangladesh